Octavalent Therapeutics Private Limited
About Octavalent Therapeutics Private Limited
Data last updated:
Octavalent Therapeutics Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 27 April 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2022PTC060642.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Prahlad Sabnani and Dinesh Bhurani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Saynani B/3 Pushvtika Pipliyahana, Indore, Madhya Pradesh, India – 452016.
Company details
Contact details
Octavalent Therapeutics Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered AddressSaynani B/3 Pushvtika Pipliyahana, Indore, Madhya Pradesh, India – 452016
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Octavalent Therapeutics Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Octavalent Therapeutics Private Limited, buy the company report.
Board of directors of Octavalent Therapeutics Private Limited
Octavalent Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prahlad Sabnani | Director | 27 Apr 2022 | 4 Years 6 Months | Current |
| Dinesh Bhurani | Director | 27 Apr 2022 | 4 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Octavalent Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Octavalent Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Octavalent Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Octavalent Therapeutics Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Dinesh Bhurani was appointed as Director on 27 Apr 2022.
Frequently asked questions
Octavalent Therapeutics is an active private limited company based in Indore, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 27 April 2022 (4+ years old) and is registered under CIN U24239MP2022PTC060642.
Octavalent Therapeutics has 2 current directors:
- Prahlad Sabnani - Director
- Dinesh Bhurani - Director
The latest financial statements of Octavalent Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Octavalent Therapeutics is U24239MP2022PTC060642. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Octavalent Therapeutics was incorporated on 27 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
Dinesh Bhurani was appointed as Director on 27 Apr 2022. Prahlad Sabnani was appointed as Director on 27 Apr 2022.
The registered office of Octavalent Therapeutics is at Saynani B3 Pushvtika Pipliyahana, Indore, Madhya Pradesh, India – 452016.
Octavalent Therapeutics operates in the chemicals industry, in the manufacturing segment.
Octavalent Therapeutics can be reached at its registered office: Saynani B3 Pushvtika Pipliyahana, Indore, Madhya Pradesh, India – 452016.
Octavalent Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
